These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19029326)

  • 1. In vitro activity of the quinolone WCK 771 against recent U.S. hospital and community-acquired Staphylococcus aureus pathogens with various resistance types.
    Bhagwat SS; McGhee P; Kosowska-Shick K; Patel MV; Appelbaum PC
    Antimicrob Agents Chemother; 2009 Feb; 53(2):811-3. PubMed ID: 19029326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of the new quinolone WCK 771 against staphylococci.
    Jacobs MR; Bajaksouzian S; Windau A; Appelbaum PC; Patel MV; Gupte SV; Bhagwat SS; De Souza NJ; Khorakiwala HF
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3338-42. PubMed ID: 15328094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antistaphylococcal activity of WCK 771, a tricyclic fluoroquinolone, in animal infection models.
    Patel MV; De Souza NJ; Gupte SV; Jafri MA; Bhagwat SS; Chugh Y; Khorakiwala HF; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4754-61. PubMed ID: 15561853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-methicillin-resistant Staphylococcus aureus quinolone WCK 771 has potent activity against sequentially selected mutants, has a narrow mutant selection window against quinolone-resistant Staphylococcus aureus, and preferentially targets DNA gyrase.
    Bhagwat SS; Mundkur LA; Gupte SV; Patel MV; Khorakiwala HF
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3568-79. PubMed ID: 16940059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro bactericidal activity of levonadifloxacin (WCK 771) against methicillin- and quinolone-resistant Staphylococcus aureus biofilms.
    Tellis M; Joseph J; Khande H; Bhagwat S; Patel M
    J Med Microbiol; 2019 Aug; 68(8):1129-1136. PubMed ID: 31241446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levonadifloxacin (WCK 771) exerts potent intracellular activity against
    Dubois J; Dubois M
    J Med Microbiol; 2019 Dec; 68(12):1716-1722. PubMed ID: 31689174
    [No Abstract]   [Full Text] [Related]  

  • 7. Susceptibilities of healthcare- and community-associated methicillin-resistant staphylococci to the novel des-F(6)-quinolone DX-619.
    Watanabe S; Ito T; Hiramatsu K
    J Antimicrob Chemother; 2007 Dec; 60(6):1384-7. PubMed ID: 17890283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
    Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virulence characteristics of community-associated Staphylococcus aureus and in vitro activities of moxifloxacin alone and in combination against community-associated and healthcare-associated meticillin-resistant and -susceptible S. aureus.
    Goldstein EJC; Citron DM; Warren YA; Tyrrell KL; Rybak MJ
    J Med Microbiol; 2008 Apr; 57(Pt 4):452-456. PubMed ID: 18349364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dichotomous selection of high-level oxacillin resistance in Staphylococcus aureus by fluoroquinolones.
    Dalhoff A; Schubert S
    Int J Antimicrob Agents; 2010 Sep; 36(3):216-21. PubMed ID: 20630710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents.
    Bogdanovich T; Esel D; Kelly LM; Bozdogan B; Credito K; Lin G; Smith K; Ednie LM; Hoellman DB; Appelbaum PC
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3325-33. PubMed ID: 16048943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growing Resistance to Vancomycin among Methicillin Resistant Staphylococcus Aureus Isolates from Different Clinical Samples.
    Pahadi PC; Shrestha UT; Adhikari N; Shah PK; Amatya R
    JNMA J Nepal Med Assoc; 2014; 52(196):977-81. PubMed ID: 26982895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream isolates in urban Detroit.
    Chua T; Moore CL; Perri MB; Donabedian SM; Masch W; Vager D; Davis SL; Lulek K; Zimnicki B; Zervos MJ
    J Clin Microbiol; 2008 Jul; 46(7):2345-52. PubMed ID: 18508934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curing bacteria of antibiotic resistance: reverse antibiotics, a novel class of antibiotics in nature.
    Hiramatsu K; Igarashi M; Morimoto Y; Baba T; Umekita M; Akamatsu Y
    Int J Antimicrob Agents; 2012 Jun; 39(6):478-85. PubMed ID: 22534508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India.
    Tiwari HK; Sen MR
    BMC Infect Dis; 2006 Oct; 6():156. PubMed ID: 17067393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducible clindamycin and methicillin resistant Staphylococcus aureus in a tertiary care hospital, Kathmandu, Nepal.
    Adhikari RP; Shrestha S; Barakoti A; Amatya R
    BMC Infect Dis; 2017 Jul; 17(1):483. PubMed ID: 28693489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftaroline pharmacodynamic activity versus community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus, heteroresistant vancomycin-intermediate S. aureus, vancomycin-intermediate S. aureus and vancomycin-resistant S. aureus using an in vitro model.
    Zhanel GG; Rossnagel E; Nichol K; Cox L; Karlowsky JA; Zelenitsky S; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2011 Jun; 66(6):1301-5. PubMed ID: 21429940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibiotic susceptibility of Staphylococcus aureus strains isolated in two university hospitals in Rabat, Morocco].
    Elhamzaoui S; Benouda A; Allali F; Abouqual R; Elouennass M
    Med Mal Infect; 2009 Dec; 39(12):891-5. PubMed ID: 19269758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital.
    Shalit I; Berger SA; Gorea A; Frimerman H
    Antimicrob Agents Chemother; 1989 Apr; 33(4):593-4. PubMed ID: 2729953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Report-Isolation identification and control of vancomycin resistant Staphylococcus aureus.
    Liaqat F; Sheikh AA; Nazir J; Hussain T; Rabbani M; Shaheen AY; Muhammad J
    Pak J Pharm Sci; 2015 May; 28(3):997-1004. PubMed ID: 26004734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.